Background World Health Organization (WHO) has recommended that countries with drug resistant malaria problem use combination therapies, especially artemisinin-based combination therapy (ACT). However, there is limited information on the efficacy of ACT in North Sulawesi. Objective To compare the efficacy of artemether-lumefantrine and artesunate plus sulfadoxine-pyrimethamine (SP). Methods This was a randomized experimental study, conducted in Prof. Dr. R. D. Kandou General Hospital, Manado from January treated with artemether-lumefantrine and artesunate plus SP. Body temperature, parasite and gametocyte count were recorded every 28. Results Fever clearance time showed a significant difference no significant difference in parasite clearance time (P>0.05) and gametocyte clearance time (P>0.05). The 28 day cure rate were Conclusion Both artemether-lumefantrine and artesunate plus SP combination are effective and safe for the treatment of falciparum malaria in children. [Paediatr Indones. 2010;50:112-7].
M alaria has been one of the most serious health problems in the world. It is an acute or chronic disease which is caused by plasmodium and transmitted million cases of malaria with 38,000 deaths every year. In North Sulawesi malaria has been one of the most frequent diseases. Among types of malaria, falciparum malaria is the most frequently found infection and can cause death. Efforts to reduce the morbidity and mortality rate are done by early diagnosis, prompt treatment, surveillance and vector control with aim to disrupt the malaria transmission. Resistance to antimalarial drugs has caused treatment failure which to chloroquine was reported in East Kalimantan and provinces of Indonesia. 2 In North Sulawesi, several studies were conducted by Rampengan et al [3] [4] [5] 
who quinine. Kan et al
World Health Organization (WHO) has recommended that countries with monotherapy drug resistance use the combination therapy, especially from artemisinin group or artemisinin-based combination therapy (ACT). Combination therapy can prevent drug resistance and increase efficacy without increasing drug toxicity. combination of artemether-lumefantrine as an option in the treatment of falciparum malaria. 8 There is still limited information on the efficacy of ACT in North Sulawesi. Based on drugs resistancy studies in North Sulawesi above we conducted a study to compare the efficacy of artemether-lumefantrine and artesunate plus SP in order to find an alternative antimalarial drugs which has high efficacy, safe, well tolerated and not expensive. Our hypotheses were that fever clearance time (FCT), parasite clearance time (PCT) and gametocyte clearance time (GCT) were faster in artemether-lumefantrine group compared to rate were greater in artemether-lumefantrine group compared to artesunate plus SP group.
Methods
A randomized experimental study was performed complicated falciparum malaria. They were randomly assigned to receive either artemether-lumefantrine or artesunate plus SP group. The study was conducted in Prof. Dr. R. D. Kandou General Hospital Manado.
with body weight more than 5 kg and diagnosed as uncomplicated falciparum malaria who did not take patients presenting with one or more signs of severe or complicated malaria, severe malnutrition, allergy co-morbidity (e.g., dengue fever, pneumonia, typhoid fever and urinary tract infection).
Patients in the artemether-lumefantrine group were given tablets containing 20 mg of artemether and once a day for three days. The dose of SP was based first day. All were taken after meal.
All patients remained hospitalized during the treatment. Study assessments were scheduled daily from the start of treatment through day seven. At each assessment, patients were evaluated to medical history, physical examination, and thick blood smear for parasitemia. Thick blood smear was taken twice a day, stained with Giemsa stain and the parasite density was calculated by counting the number of asexual parasites per 200 white blood cells, based on the white blood cell count of each patient. The body temperature was assessed every six hours. Fever was
The patients took antipyretic (paracetamol) if the The body temperature and thick blood smear were taken on each visiting. During the study, all patients were applied with mosquito repellent.
Primary outcome measures
Parasite clearance time (PCT) was defined as time (hour) from the first dose until first total and continued disappearance of asexual parasite forms that clearance time (FCT) was defined as time (hour) from the first dose until the first time the body temperature clearance time as the time from the first dose until the first total and continued disappearance of gametocyte hours. Day seven cure rate was the proportion of patients with clearance of asexual parasitemia within seven days of initiation of trial treatment, without subsequent recrudescence within these seven days.
patients with clearance of asexual parasitemia within seven days of initiation of trial medication, without study start. Day 28 cure rate was considered to be of greatest importance, and defined as the proportion of patients with clearance of asexual parasitemia within seven days of initiation of trial drug, without subsequent recrudescence within 28 days after study start. Recrudescence was defined as the existence of positive blood smears after initial clearance of parasites from the peripheral blood.
Parasite clearance time, fever clearance time and gametocyte clearance time were analyzed using Manncure rate, and side effects were presented descriptively. 
Results
There were 2 patients dropped out in this study because they refused to continue the medication and completed (Figure 1) . apparent significant difference between both groups except that The mean parasite density was lower in the artemether-lumefantrine group compared to Table 1 ). The median of PCT was same in both groups FCT data suggested a more rapid resolution of fever with artesunate plus SP treatment than artemetherlumefantrine. For artesunate plus SP group, the was no significant difference in GCT between the two groups. The median GCT in artesunate plus SP group was 20 hours and for artemether-lumefantrine Table 2 ). No side effect was observed.
Discussion
We have shown that both treatment regimens for children with uncomplicated falciparum malaria were similar in terms of PCT, GCT and cure rate, but the FCT was more rapid in artesunate plus SP group. The median FCT in artesunate plus SP by others, such as Mohamed et al 9 In this study, the baseline characteristic of parasite density was significantly different in both group, artesunate plus SP group had higher parasite density could affect the result.
The eradication of gametocyte can lead to malaria elimination. Gametocyte is an important key in epidemiology because it has relation with the vector and host infection cycle. Both regimens were effective in gametocyte clearance. There was no significant difference in both groups. Guttmann et al found one patient with positive gametocyte in artesunate and amodiaquine group and five patients in artemetherlumefantrine group.
Cure rate in malaria treatment is usually defined as 28 day cure rate. It shows the ability of antimalarial drug to eliminate the whole parasite during the infection. Cure rate depends on several factor such as resistence, parasite burden, and immunity. Both regimens in this study showed a very high cure rate of artesunate and SP.
We found no side effect in both treatments. In conclusion this study shows that both combinations (artesunate plus SP or artemetherlumefantrine) drugs are effective, safe and well tolerated for the treatment of uncomplicated malaria in children.
